Is this you? Create Your Porfile
Avatar

Baohoang Lam

Merck & Co.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Baohoang Lam is active.

Explore More

Publication

Featured researches published by Baohoang Lam.

Journal of Clinical Oncology | 2017

Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC.

Luis A. Diaz; Aurelien Marabelle; Jean-Pierre Delord; Ronnie Shapira-Frommer; Ravit Geva; Nir Peled; Tae Won Kim; Thierry André; Eric Van Cutsem; Rosine Guimbaud; Dirk Jaeger; Elena Elez; Takayuki Yoshino; Andrew K. Joe; Baohoang Lam; Christine K. Gause; Scott K. Pruitt; S. Peter Kang; Dung T. Le

Journal of Clinical Oncology | 2016

KEYNOTE-062: Phase 3 study of pembrolizumab alone or in combination with chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Josep Tabernero; Yung-Jue Bang; Charles S. Fuchs; Atsushi Ohtsu; Uma Kher; Baohoang Lam; Minori Koshiji; Eric Van Cutsem

Annals of Oncology | 2017

386PEfficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers

Luis A. Diaz; Aurelien Marabelle; Taeeun Kim; Ravit Geva; E. Van Cutsem; T. André; P.A. Ascierto; M. Maio; J-P. Delord; Maya Gottfried; Rosine Guimbaud; Dirk Jaeger; Elena Elez; Takayuki Yoshino; Andrew K. Joe; Baohoang Lam; J. Ding; Scott K. Pruitt; Soonmo Peter Kang; Dung T. Le

Journal of Clinical Oncology | 2016

Preliminary safety data from KEYNOTE-059: Pembrolizumab plus 5-fluorouracil (5-FU) and cisplatin for first-line treatment of advanced gastric cancer.

Charles S. Fuchs; Atsushi Ohtsu; Josep Tabernero; Eric Van Cutsem; Jiang Dian Wang; Baohoang Lam; Rita P. Dalal; Minori Koshiji; Yung-Jue Bang

Journal of Clinical Oncology | 2017

KEYNOTE-177: Randomized phase III study of pembrolizumab versus investigator-choice chemotherapy for mismatch repair-deficient or microsatellite instability-high metastatic colorectal carcinoma.

Luis A. Diaz; Dung T. Le; Takayuki Yoshino; Thierry André; Johanna C. Bendell; Minori Koshiji; Yinghua Zhang; S. Peter Kang; Baohoang Lam; Dirk Jäger

Journal of Clinical Oncology | 2016

KEYNOTE-177: First-line, open-label, randomized, phase III study of pembrolizumab (MK-3475) versus investigator-choice chemotherapy for mismatch repair deficient or microsatellite instability-high metastatic colorectal carcinoma.

Luis A. Diaz; Dung T. Le; Takayuki Yoshino; Thierry André; Johanna C. Bendell; Yinghua Zhang; Baohoang Lam; Minori Koshiji; Dirk Jäger

Journal of Clinical Oncology | 2015

Multicohort phase II KEYNOTE-059 study of pembrolizumab (MK-3475) for recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Charles S. Fuchs; Andrew E. Denker; Josep Tabernero; Eric Van Cutsem; Atsushi Ohtsu; Baohoang Lam; Minori Koshiji; Yung-Jue Bang

Annals of Oncology | 2015

P-105Pembrolizumab (MK-3475) for patients with recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma: The phase 2 KEYNOTE-059 study

Charles S. Fuchs; Andrew E. Denker; Josep Tabernero; E. Van Cutsem; Atsushi Ohtsu; Baohoang Lam; Minori Koshiji; Yung-Jue Bang

Journal of Clinical Oncology | 2016

Pembrolizumab (MK-3475) plus 5-fluorouracil (5-FU) and cisplatin for first-line treatment of advanced gastric cancer: Preliminary safety data from KEYNOTE-059.

Charles S. Fuchs; Atsushi Ohtsu; Josep Tabernero; Eric Van Cutsem; Jiang Dian Wang; Baohoang Lam; Minori Koshiji; Yung-Jue Bang

Journal of Clinical Oncology | 2016

Pembrolizumab (MK-3475) for recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma: Multicohort phase II KEYNOTE-059 study.

Charles S. Fuchs; Andrew E. Denker; Josep Tabernero; Eric Van Cutsem; Atsushi Ohtsu; Baohoang Lam; Minori Koshiji; Yung-Jue Bang

Explore More

Collaboration

Dive into the Baohoang Lam's collaboration.

Top Co-Authors
Avatar

Minori Koshiji

Merck

View shared research outputs
Top Co-Authors
Avatar

Charles S. Fuchs

Yale Cancer Center

View shared research outputs
Top Co-Authors
Avatar

Atsushi Ohtsu

Juntendo University

View shared research outputs
Top Co-Authors
Avatar

Yung-Jue Bang

Seoul National University Hospital

View shared research outputs
Top Co-Authors
Avatar

Eric Van Cutsem

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors
Avatar

Andrew E. Denker

Merck

View shared research outputs
Top Co-Authors
Avatar

Luis A. Diaz

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors
Avatar

Takayuki Yoshino

University of Tsukuba

View shared research outputs
Top Co-Authors
Avatar

Dung T. Le

Johns Hopkins University

View shared research outputs
Top Co-Authors
Avatar

E. Van Cutsem

Katholieke Universiteit Leuven

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge